Vincent Perrone | Head Investor Relations |
Liz Barrett | President and Chief Executive Officer |
Mark Schoenberg | Chief Medical Officer |
Jeff Bova | Chief Commercial Officer |
Don Kim | Chief Financial Officer |
Raghuram Selvaraju | H.C. Wainwright |
Boris Peaker | TD Cowen |
Leland Gershell | Oppenheimer |
Matt Kaplan | Ladenburg Thalmann |
Good morning, ladies and gentlemen. Thank you for standing by. And welcome to the UroGen Pharma’s Second Quarter 2023 Earnings Call. Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Vincent Perrone, Head Investor Relations.